Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 37 citing Ekberg: C-peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy. (0.14 sec) 

Gateways to clinical trials


M Bayes, X Rabasseda, JR Prous - Methods and findings in experimental and clinical …, 2006 - journals.prous.com
Contributing Editors: P. Cole, C. Orellana, JA Vallès, RM a . Antonijoan, KP
Mohana Priya, M. Priya, V. Renuga, R. Sree Lekha, B. Priya, A. Tomillero, G.
Krithiga and E. Banu Rekha.
Cited by 148 - Related articles - All 9 versions

C-peptide is a bioactive peptide


J Wahren, K Ekberg, H Jörnvall - Diabetologia, 2007 - Springer
Page 1. FOR DEBATE C-peptide is a bioactive peptide J. Wahren & K. Ekberg
& H. Jörnvall Received: 8 June 2006 /Accepted: 24 October ...
Cited by 28 - Related articles - BL Direct - All 4 versions

Treatment of diabetic neuropathy and neuropathic pain


D Ziegler - Diabetes care, 2008 - Am Diabetes Assoc
At least one of four diabetic patients is affected by distal symmetric
polyneuropathy, which represents a major health problem, since it may present
with partly excruciating neuropathic pain and is responsible for ...
Cited by 26 - Related articles - BL Direct - All 5 versions

Approaches to prevention of cardiovascular complications and events in diabetes mellitus

- adisonline.com [PDF] 
S Coccheri - Drugs, 2007 - ingentaconnect.com
Abstract. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . 998 1. Introduction . . . . . . . . . . . . . . . . . . . . . ...
Cited by 22 - Related articles - BL Direct - All 9 versions

Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-κB …


V Cifarelli, P Luppi, HM Tse, J He, J Piganelli … - Atherosclerosis, 2008 - Elsevier
Excessive proliferation of vascular smooth muscle cells (VSMCs) is one of the
primary lesions in atherosclerosis development during diabetes. High glucose
triggers VSMC proliferation and initiates activation of the transcription ...
Cited by 12 - Related articles - All 21 versions

Growth factors as therapeutics for diabetic neuropathy


NA Calcutt, CG Jolivalt, P Fernyhough - Current Drug Targets, 2008 - ingentaconnect.com
Abstract: There has been a rapid growth in appreciation of the diverse array of
neurotrophic factors, growth factors and other biological molecules that have
the capacity to support adult neurons and direct reparative processes after ...
Cited by 9 - Related articles - BL Direct - All 2 versions

Clinical manifestations and current treatment options for diabetic neuropathies


CM Casellini, AI Vinik - Endocrine Practice, 2007 - AACE
Submitted for publication April 14, 2007 Accepted for publication June 4, 2007
From the Leonard Strelit iabete e earch
n titute , a tern ir inia Strelit ...
Cited by 10 - Related articles - BL Direct - All 7 versions

Painful diabetic neuropathy: treatment and future aspects


D Ziegler - Diabetes/Metabolism Reviews - interscience.wiley.com
Around one of three diabetic patients is affected by distal symmetric
polyneuropathy (DSP) which represents a major health problem, as it may present
with partly excruciating neuropathic pain and is responsible for ...
Cited by 9 - Related articles - BL Direct - All 3 versions

Diabetic polyneuropathy: an update

- prsjournal.com
DW Zochodne - Current opinion in neurology, 2008 - journals.lww.com
Recent findings: Diabetic neuropathies are common and rising in prevalence with
the global burden of type 2 diabetes. Polyneuropathy is also emerging as a
complication of impaired glucose tolerance, without frank diabetes. Ideas ...
Cited by 9 - Related articles - All 9 versions

Human C-peptide antagonises high glucose-induced endothelial dysfunction through the …


P Luppi, V Cifarelli, H Tse, J Piganelli, M … - Diabetologia, 2008 - Springer
Abstract Aims/hypothesis Endothelial dysfunction in diabetes is pre- dominantly
caused by hyperglycaemia leading to vascular complications through
overproduction of oxidative stress and activation of the transcription ...
Cited by 5 - Related articles - All 2 versions


Result Page: 

1

2

3

4

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google